Verathon

Verathon is a company specializing in advanced medical devices that enhance airway management and bladder scanning procedures, delivering innovative solutions to healthcare providers. Verathon Inc. develops advanced medical devices focused on airway management, bronchoscopy, and bladder scanning. The company is headquartered in Bothell, US.

In December 2009, Roper Industries Inc. acquired Verathon for an undisclosed amount. The company has received a total of USD 34. 00 mn in funding, with the latest funding round occurring on December 8, 2009, led by DW Healthcare Partners and RHO Capital Partners.

Verathon Inc. specializes in advanced medical devices focused on airway management, bronchoscopy, and bladder scanning. Its flagship products include the GlideScope® ClearFit™, a cover-based video laryngoscope that enhances airway management efficiency through a reusable video baton paired with a variety of single-use covers for diverse clinical scenarios. Additionally, the company offers the GlideScope® Spectrum™ QC product line, which has expanded to include single-use video laryngoscopes specifically designed for neonatal and pediatric care, improving intubation success rates for younger patients.

These products are marketed to healthcare providers such as hospitals and emergency medical services across regions including North America, Europe, and select markets in Asia, ensuring that clinicians have the tools needed to navigate a variety of patient needs effectively. Verathon’s commitment to innovation is underscored by its introduction of the Spectrum QC eco, the first single-use video laryngoscope made from bio-based plastics, combining eco-friendliness with high performance. Verathon Inc. 's revenue generation model is primarily based on direct sales of its medical devices to healthcare institutions, including hospitals and clinics.

The company engages in B2B transactions, supplying its advanced airway management and bladder scanning solutions directly to healthcare providers, which facilitates efficient procurement processes tailored to the needs of clinical environments. Typically, customers place orders for products like the GlideScope® ClearFit™ and the Spectrum QC series, which may be utilized in various emergency and elective procedures. The pricing structure is designed to reflect the advanced technology and effectiveness of the devices, ensuring that healthcare providers receive reliable solutions that enhance patient care. Verathon's market strategy emphasizes building long-term partnerships with healthcare systems, thereby supporting ongoing clinical needs with a focus on both performance and sustainability in healthcare practices.

Verathon plans to introduce new products aimed at enhancing clinical outcomes, with specific designs for upcoming airway management devices scheduled for launch over the next two years. The company is strategizing to expand its market presence in Europe and Asia by 2025. The recent funding of USD 34. 00 mn will be utilized to support these product developments and market expansion initiatives.